Akron
#JaylandWalker: Jayland Walker Reportedly Shot 60 Times By Akron Police, Details Are Scant
HipHopWired Featured Video CLOSE Source: Douglas Sacha / Getty Jayland Walker is the latest victim of a police-related shooting, and the event’s details are still developing. Walker was reportedly a DoorDash driver who was stopped for a traffic violation, but things went left when eight officers fired 90 shots and reportedly struck him 60 times. Local outlet WKYC obtained details of the shooting including an autopsy of Walker’s body, confirming that he was indeed hit with several bullets after police fired over 90 shots following a traffic chase this past Monday (June 27) in Akron, Ohio. The excessive barrage of gunfire caught the ire and criticism of activists both on the ground and online, and it’s since come out that Walker was unarmed. Police bodycam footage of the shooting has not bee...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
